期刊文献+

药品GMP检查员胜任力模型构建及实证研究 被引量:8

Construction of competence model for GMP inspectors and empirical research
原文传递
导出
摘要 目的:构建药品GMP检查员胜任力模型,为药品GMP检查员相关制度建设提供参考。方法:采用问卷调查和专家讨论的形式调研了药品GMP检查员的胜任力特征,对调研结果进行了汇总和提取,构建了药品GMP检查员胜任力模型。利用实证研究的方法对B市药品GMP检查员开展了问卷调查,分析了调查结果的信度和效度,对构建的胜任力模型进行了验证。结果:调查问卷的Cronbach'sα系数为0.786,KMO值为0.797,Bartlett球形度检验近似χ~2值为6 391.542(P<0.000),解释的总方差为81.19%。结论:胜任力模型通过了Cronbach'sα系数、KMO值检验和Bartlett球形度检验,表面效度、内容效度和架构效度较高。 Objective : To construct the competency model of drug GMP inspectors, and provide reference for construction of relevant system of drug GMP inspectors. Methods: the competency characteristics of drug GMP inspectors were investigated by means of questionnaire and expert interview. The research results were summarized and extracted, and the competency model of drug GMP inspectors was constructed. Then the method of empirical research was used to carry out a questionnaire survey of GMP inspectors in city B, and the reliability and validity of the survey results were analyzed. Results: The Cronbach's alpha coefficient of the questionnaire was 0. 786, the KMO value was 0. 797, and the Bartlett sphericity test was approximated by chi 2, and the value was 6 391. 542 (P 〈0. 000), and the total variance explained was 81. 19%. Conclusion: the competency model through the Cronbach's alpha coefficient, KMO value test and Bartlett spherical degree test, the surface validity, content validity and structure validity is high.
出处 《中国新药杂志》 CAS CSCD 北大核心 2017年第16期1861-1864,共4页 Chinese Journal of New Drugs
关键词 药品GMP检查员 胜任力 模型 构建 drug GMP inspector competence model construction
  • 相关文献

参考文献2

二级参考文献16

  • 1姜典才,林朝霞,张洁,徐丽洁,陈玉琴,李凤祥,周国安.对我国GMP发展的几点思考[J].中国药事,2006,20(4):244-246. 被引量:17
  • 2药品管理法实施条例[S].国务院令第360号,2002.
  • 3国家药品监督管理局.关于公布第一批国家药品GMP认证检查员名单的通知[Z].国药监安[2002]441号,2002.
  • 4国家食品药品监督管理局.关于公布第二批国家药品GMP认证检查员名单的通知[Z].国食药监安[2003]30号,2003.
  • 5国家食品药品监督管理局.关于公布第三批国家药品GMP认证检查员名单的通知[Z].国食药监安[2003]80号,2003.
  • 6国家食品药品监督管理局.关于公布第四批国家药品GMP认证检查员名单的通知[Z].国食药监安[2004]185号,2004.
  • 7国家食品药品监督管理局.药品生产质量管理规范认证管理办法[Z].国药监安[2002]442号,2002.
  • 8FDA. Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach-Progress Report of the Pharmaceutical Inspectorate Working Group[EB/OL].[2008-07-30]. http: //www. fda. gov/cder/gmp/pharminspectorate, htm.
  • 9FDA. Pharmaceutical Inspectorate (PI) Frequently Asked Questions[EB/OL].[2008-07-30].http: // www. fda. gov/eder/gmp/PI-q&a. htm.
  • 10Bailey K D. Methods of Social Research (4th edition)[M]. New York:The Free Press,1994.115-165.

共引文献362

同被引文献55

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部